Nova Mentis Life Science Corp (TSE:NOVA) has released an update.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Nova Mentis Life Science Corp., a Canadian biotech leader in neuroinflammatory diagnostics and therapeutics, has announced the addition of experienced entrepreneur Steve Loutskou to its Board of Directors. Loutskou, known for his strategic vision and financial expertise, has a track record of advancing start-ups and attracting investments. His appointment is expected to bolster Nova’s business strategies and operations.
For further insights into TSE:NOVA stock, check out TipRanks’ Stock Analysis page.